Literature DB >> 9234515

Expression and immunogenicity of Mycobacterium tuberculosis antigen 85 by DNA vaccination.

J B Ulmer1, M A Liu, D L Montgomery, A M Yawman, R R Deck, C M DeWitt, J Content, K Huygen.   

Abstract

Plasmid DNA expression vectors encoding Mycobacterium tuberculosis antigen 85 (Ag85) were tested as vaccines in preclinical animal models. Expression of secreted and nonsecreted forms of Ag85 was observed after transient transfection of cells in vitro. In mice, both types of Ag85 DNA constructs induced strong humoral and cell-mediated immune responses, as measured by ELISA of sera and recall responses of spleen cells restimulated in vitro, respectively, Therefore, DNA vaccination is an effective means of expressing mycobacterial proteins in eukaryotic cells leading to the induction of potent immune responses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234515     DOI: 10.1016/s0264-410x(96)00255-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  CBA/J mice generate protective immunity to soluble Ag85 but fail to respond efficiently to Ag85 during natural Mycobacterium tuberculosis infection.

Authors:  Gillian L Beamer; Joshua Cyktor; David K Flaherty; Paul C Stromberg; Bridget Carruthers; Joanne Turner
Journal:  Eur J Immunol       Date:  2012-04       Impact factor: 5.532

2.  DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis.

Authors:  Giovanni Delogu; Amy Li; Charlene Repique; Frank Collins; Sheldon L Morris
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

3.  T-cell responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 in Brazilian tuberculosis patients.

Authors:  Fernando L L Cardoso; Paulo R Z Antas; Alexandre S Milagres; Annemieke Geluk; Kees L M C Franken; Eliane B Oliveira; Henrique C Teixeira; Susie A Nogueira; Euzenir N Sarno; Paul Klatser; Tom H M Ottenhoff; Elizabeth P Sampaio
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

4.  Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis.

Authors:  Hans Joachim Mollenkopf; Leander Grode; Jens Mattow; Maik Stein; Peggy Mann; Bernhard Knapp; Jeffrey Ulmer; Stefan H E Kaufmann
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

5.  Protection against virulent Mycobacterium avium infection following DNA vaccination with the 35-kilodalton antigen is accompanied by induction of gamma interferon-secreting CD4(+) T cells.

Authors:  E Martin; A T Kamath; J A Triccas; W J Britton
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

6.  CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis.

Authors:  B L Freidag; G B Melton; F Collins; D M Klinman; A Cheever; L Stobie; W Suen; R A Seder
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

7.  Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis.

Authors:  S D'Souza; V Rosseels; M Romano; A Tanghe; O Denis; F Jurion; N Castiglione; A Vanonckelen; K Palfliet; Kris Huygen
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

8.  Poly (lactide-co-glycolide) microspheres in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85B.

Authors:  Dongmei Lu; Lucila Garcia-Contreras; Ding Xu; Sherry L Kurtz; Jian Liu; Miriam Braunstein; David N McMurray; Anthony J Hickey
Journal:  Pharm Res       Date:  2007-07-27       Impact factor: 4.200

9.  Induction of protective cellular immunity against Mycobacterium tuberculosis by recombinant attenuated self-destructing Listeria monocytogenes strains harboring eukaryotic expression plasmids for antigen 85 complex and MPB/MPT51.

Authors:  Keita Miki; Toshi Nagata; Takao Tanaka; Yeung-Hyen Kim; Masato Uchijima; Naoya Ohara; Satoshi Nakamura; Masaji Okada; Yukio Koide
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

10.  Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapy.

Authors:  Javaid A Sheikh; Gopal K Khuller; Indu Verma
Journal:  J Immune Based Ther Vaccines       Date:  2011-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.